nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
|
Phillips, Andrew N |
|
2018 |
5 |
3 |
p. e146-e154 |
artikel |
2 |
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial
|
Mercié, Patrick |
|
2018 |
5 |
3 |
p. e126-e135 |
artikel |
3 |
Innovation challenge contests to enhance HIV responses
|
Tucker, Joseph D |
|
2018 |
5 |
3 |
p. e113-e115 |
artikel |
4 |
¡PrEP Ya! Latin America wants PrEP, and Brazil leads the way
|
Galea, Jerome T |
|
2018 |
5 |
3 |
p. e110-e112 |
artikel |
5 |
Prevention of HIV transmission by antiretroviral therapy
|
Lundgren, Jens |
|
2018 |
5 |
3 |
p. e108-e109 |
artikel |
6 |
Resistance to first-line ART and a role for dolutegravir
|
Kaplan, Richard |
|
2018 |
5 |
3 |
p. e112-e113 |
artikel |
7 |
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
|
Grinsztejn, Beatriz |
|
2018 |
5 |
3 |
p. e136-e145 |
artikel |
8 |
Shared goals for tuberculosis and HIV
|
The Lancet HIV, |
|
2018 |
5 |
3 |
p. e107 |
artikel |
9 |
Smoking and HIV: confronting the epidemic
|
Diaz, Philip |
|
2018 |
5 |
3 |
p. e109-e110 |
artikel |
10 |
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
|
Iwuji, Collins C |
|
2018 |
5 |
3 |
p. e116-e125 |
artikel |